REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

Exenatide Dosage and Protocols

Exenatide dosage protocols reported in published research, plus reconstitution and storage.

RE
Compiled from published research · Continuously updated

Two Formulations

Byetta is dosed at 5mcg subcutaneously twice daily, within 60 minutes before the two largest meals of the day, increasing to 10mcg BID after one month if tolerated. Bydureon (extended-release microspheres) is dosed at a fixed 2mg once weekly, any time of day, without regard to meals — the two formulations are not interchangeable on a mcg-for-mcg basis.

Reported protocol doses

Standard dose5–10 mcg BID · 2mg weekly (XR)
Frequencysee formulation
Routessubcutaneous

Doses shown are those reported in published research, not a recommendation.

All Exenatide sections

Retatrutide

fat loss & metabolismAgrade

An investigational triple GIP/GLP-1/glucagon receptor agonist producing some of the largest average weight reductions reported for a single agent.

Liraglutide

fat loss & metabolismSgrade

A once-daily GLP-1 receptor agonist — the class predecessor to semaglutide and tirzepatide, still widely prescribed under Victoza and Saxenda.

Orforglipron

fat loss & metabolismSgrade

The first oral, non-peptide GLP-1 receptor agonist pill with no food or water restrictions — FDA-approved in 2026 as Foundayo.

Put the whole protocol
in one place.

Download nowGet Now